Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GlucoTrack Inc GCTK

Healthcare Medical Devices
GlucoTrack, Inc. is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is developing an implantable continuous glucose monitoring (CGM) for use by Type 1 diabetes patients as well as insulin-dependent Type 2 patients. It is developing an implantable continuous blood glucose monitor (CBGM). This product is designed to have an... see more

Recent & Breaking News (NDAQ:GCTK)

GLUCOTRACK PROVIDES SHAREHOLDER UPDATE

GlobeNewswire March 14, 2023

GlucoTrack (NASDAQ:GCTK) announced that Mark Tapsak Ph.D. has joined the company as Vice President of Sensor Technology

John Ballem  October 27, 2022

GLUCOTRACK ANNOUNCES THE HIRING OF DR. MARK TAPSAK

GlobeNewswire October 14, 2022

GlucoTrack (NDAQ:GCTK) announces R&D program

John Ballem  October 12, 2022

GLUCOTRACK TO BEGIN RESEARCH & DEVELOPMENT OF NOVEL CONTINUOUS GLUCOSE MONITORING SYSTEM

GlobeNewswire October 10, 2022

No pain, no blood: BETTER Type 2 diabetes testing is coming to market

Jeff Nielson September 28, 2022

GlucoTrack, Inc. Provides Development Update on its Gen 2 Non-Invasive Glucose Monitor

GlobeNewswire June 22, 2022

GlucoTrack, Inc. Announces Effectiveness of Corporate Name Change and Ticker Symbol Change

GlobeNewswire March 14, 2022

Integrity Applications Issues Shareholder Update Letter

GlobeNewswire December 20, 2021

Integrity Applications Announces Uplisting to Nasdaq Capital Market

GlobeNewswire December 8, 2021

Integrity Applications, Inc. Expands U.S. Operations with the hiring of James P. Thrower, PhD, as Vice President of Engineering

GlobeNewswire December 6, 2021

Integrity Applications Announces Name Change to GlucoTrack, Inc.

GlobeNewswire November 29, 2021

Integrity Applications Announces the Appointment of Paul V. Goode, PhD, as President and Chief Operating Officer

GlobeNewswire October 21, 2021

Integrity Applications, Inc. Announces Filing of Form S-3 Shelf Registration Statement

GlobeNewswire September 20, 2021

Integrity Applications, Inc. Implements Reverse Stock Split To Meet NASDAQ Initial Listing Requirements

GlobeNewswire August 12, 2021

Integrity Applications Appoints Luis J. Malavé to Board of Directors

GlobeNewswire June 22, 2021

Integrity Applications Announces the Appointment of David C. Klonoff, MD as Chair of Scientific Advisory Board

GlobeNewswire April 21, 2021

Integrity Applications Issues Shareholder Update Letter

GlobeNewswire February 18, 2021

Integrity Applications Announces the Promotion of Erez Ben-Zvi to General Manager

GlobeNewswire February 2, 2021

Integrity Applications Appoints Paul V. Goode, PhD, to Board of Directors

GlobeNewswire December 17, 2020